Atezolizumab vs Donepezil

## Atezolizumab vs Donepezil: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Donepezil**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Donepezil**: Reversible acetylcholinesterase inhibitor.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Donepezil — 70 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Donepezil — C24H29NO3.

**Molecular Weight**: Atezolizumab — N/A; Donepezil — 379.4920 g/mol.

**Type**: Atezolizumab — Antibody; Donepezil — Small molecule.